相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models
Tianxia Li et al.
HUMAN MOLECULAR GENETICS (2014)
Parkinson disease-associated mutation R1441H in LRRK2 prolongs the active state of its GTPase domain
Jingling Liao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Rationally Designed Multi-Targeted Agents Against Neurodegenerative Diseases
W. J. Geldenhuys et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Fragment-Based Drug Discovery of 2-Thiazolidinones as Inhibitors of the Histone Reader BRD4 Bromodomain
Lele Zhao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Leucine-rich repeat kinase 2 inhibitors: a patent review (2006-2011)
Xianming Deng et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease
Byoung Dae Lee et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
LRRK2 as a therapeutic target in Parkinson's disease
E. K. Tan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Development of a mechanism-based high-throughput screen assay for leucine-rich repeat kinase 2-Discovery of LRRK2 inhibitors
Min Liu et al.
ANALYTICAL BIOCHEMISTRY (2010)
Kinetic Mechanistic Studies of Wild-Type Leucine-Rich Repeat Kinase2: Characterization of the Kinase and GTPase Activities
Min Liu et al.
BIOCHEMISTRY (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S
Xianting Li et al.
JOURNAL OF NEUROSCIENCE (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease
Byoung Dae Lee et al.
NATURE MEDICINE (2010)
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Mark R. Cookson
NATURE REVIEWS NEUROSCIENCE (2010)
GTPase Activity Plays a Key Role in the Pathobiology of LRRK2
Yulan Xiong et al.
PLOS GENETICS (2010)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Molecular pathways of neurodegeneration in Parkinson's disease
TM Dawson et al.
SCIENCE (2003)
分享论文
